• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射奎尼丁治疗严重恶性疟。临床及药代动力学研究。

Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.

作者信息

Phillips R E, Warrell D A, White N J, Looareesuwan S, Karbwang J

出版信息

N Engl J Med. 1985 May 16;312(20):1273-8. doi: 10.1056/NEJM198505163122001.

DOI:10.1056/NEJM198505163122001
PMID:3887162
Abstract

Quinidine has proved more effective than quinine against chloroquine-resistant Plasmodium falciparum both in vitro and in patients with uncomplicated disease. To examine the effectiveness and pharmacokinetics of quinidine for this use, we treated 14 patients who had severe falciparum malaria with intravenous quinidine gluconate; a loading dose of 15 mg of the base per kilogram of body weight was followed by 7.5 mg per kilogram every eight hours. Two of the five patients with cerebral malaria died, but parasitemia was eliminated in the 12 survivors. Two patients had recurrent parasitemia on Days 25 and 28. Times required for parasite clearance and elimination of fever (49.4 +/- 17.8 and 69.5 +/- 18.7 hours, respectively) were comparable to those in earlier studies with a loading dose of quinine. Quinidine appears to have a larger volume of distribution than quinine. The elimination half-life was 12.8 hours, the volume of distribution was 1.68 liters per kilogram, total clearance was 1.75 ml per kilogram per minute, and urinary clearance was 0.62 ml per kilogram per minute. Electrocardiographic changes were common but there were no dysrhythmias. In two patients, blood pressure fell during the initial infusion of quinidine. Quinidine gluconate is more widely available than quinine in many countries, and our findings show that it is effective in severe falciparum malaria.

摘要

在体外实验以及针对非复杂性疾病患者的治疗中,奎尼丁已被证明在对抗氯喹耐药的恶性疟原虫方面比奎宁更有效。为了研究奎尼丁用于此用途的有效性和药代动力学,我们用静脉注射葡萄糖酸奎尼丁治疗了14例严重恶性疟疾病例;先给予每千克体重15毫克碱基的负荷剂量,随后每八小时给予每千克体重7.5毫克。五例脑型疟患者中有两例死亡,但12名幸存者的疟原虫血症被清除。两名患者在第25天和第28天出现疟原虫血症复发。疟原虫清除和退热所需时间(分别为49.4±17.8小时和69.5±18.7小时)与早期使用奎宁负荷剂量的研究结果相当。奎尼丁的分布容积似乎比奎宁大。消除半衰期为12.8小时,分布容积为每千克体重1.68升,总清除率为每分钟每千克体重1.75毫升,尿清除率为每分钟每千克体重0.62毫升。心电图改变很常见,但未出现心律失常。两名患者在最初输注奎尼丁时血压下降。在许多国家,葡萄糖酸奎尼丁比奎宁更容易获得,我们的研究结果表明它对严重恶性疟疾有效。

相似文献

1
Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.静脉注射奎尼丁治疗严重恶性疟。临床及药代动力学研究。
N Engl J Med. 1985 May 16;312(20):1273-8. doi: 10.1056/NEJM198505163122001.
2
Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion.在美国,采用葡萄糖酸奎尼丁持续输注和换血疗法治疗重症疟疾。
N Engl J Med. 1989 Jul 13;321(2):65-70. doi: 10.1056/NEJM198907133210201.
3
[The anti-arrhythmia drug quinidine as an alternative in the treatment of severe falciparum malaria].[抗心律失常药物奎尼丁作为重症恶性疟治疗的替代药物]
Schweiz Med Wochenschr. 1983 Feb 19;113(7):254-8.
4
Treatment of severe Plasmodium falciparum malaria with quinidine gluconate: discontinuation of parenteral quinine from CDC drug service.用葡萄糖酸奎尼丁治疗严重恶性疟原虫疟疾:美国疾病控制与预防中心药物服务部门停止使用胃肠外奎宁
MMWR Morb Mortal Wkly Rep. 1991 Apr 12;40(14):240.
5
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.青蒿琥酯口服制剂与奎宁加四环素治疗急性非复杂性恶性疟的比较。
Bull World Health Organ. 1994;72(2):233-8.
6
In vivo and in vitro responses to quinine and quinidine of Plasmodium falciparum.恶性疟原虫对奎宁和奎尼丁的体内及体外反应
Bull World Health Organ. 1988;66(3):347-52.
7
[Continuous quinidine infusion and blood exchange transfusion in severe tropical malaria: a case report].[严重热带疟疾的奎尼丁持续输注和换血疗法:一例报告]
Schweiz Med Wochenschr. 1991 Sep 14;121(37):1336-9.
8
Ineffectiveness of continuous quinidine gluconate infusion in the treatment of severe chloroquine-resistant Plasmodium falciparum malaria.连续输注葡萄糖酸奎宁治疗严重氯喹耐药恶性疟原虫疟疾无效。
Drug Intell Clin Pharm. 1988 Nov;22(11):883-5. doi: 10.1177/106002808802201110.
9
A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria.一项随机开放标签临床试验,比较静脉注射奎宁后口服马拉隆与静脉注射奎宁后口服奎宁治疗重症疟疾的疗效和安全性。
J Trop Pediatr. 2005 Feb;51(1):17-24. doi: 10.1093/tropej/fmh069. Epub 2004 Dec 15.
10
A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria.蒿甲醚或奎宁治疗越南成年重症恶性疟的对照试验。
N Engl J Med. 1996 Jul 11;335(2):76-83. doi: 10.1056/NEJM199607113350202.

引用本文的文献

1
Anti-plasmodial activity of ethanolic extract of root and stem back of Cassia sieberiana DC on mice.腊肠树根茎乙醇提取物对小鼠的抗疟活性
J Intercult Ethnopharmacol. 2015 Apr-Jun;4(2):96-101. doi: 10.5455/jice.20141231014333. Epub 2015 Jan 20.
2
Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.一名坦桑尼亚儿科移民患严重疟疾并伴有葡萄糖-6-磷酸脱氢酶缺乏症
J Pediatr Pharmacol Ther. 2014 Oct-Dec;19(4):325-34. doi: 10.5863/1551-6776-19.4.325.
3
Cardiac complications of unwitting co-injection of quinine/quinidine with heroin in an intravenous drug user.
静脉注射吸毒者无意中将奎宁/奎尼丁与海洛因共同注射导致的心脏并发症。
J Gen Intern Med. 2012 Dec;27(12):1722-5. doi: 10.1007/s11606-012-2089-2. Epub 2012 May 17.
4
Cerebral malaria: optimising management.脑型疟疾:优化治疗
CNS Drugs. 2003;17(3):153-65. doi: 10.2165/00023210-200317030-00002.
5
Crystal structure of (-)-mefloquine hydrochloride reveals consistency of configuration with biological activity.盐酸(-)-甲氟喹的晶体结构揭示了其构型与生物活性的一致性。
Antimicrob Agents Chemother. 2002 May;46(5):1529-34. doi: 10.1128/AAC.46.5.1529-1534.2002.
6
Cerebral malaria.脑型疟疾
J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):433-41. doi: 10.1136/jnnp.69.4.433.
7
Steroids for treating cerebral malaria.用于治疗脑型疟疾的类固醇。
Cochrane Database Syst Rev. 2000;1999(2):CD000972. doi: 10.1002/14651858.CD000972.
8
Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.奎宁、氯喹和阿莫地喹的药代动力学。临床意义。
Clin Pharmacokinet. 1996 Apr;30(4):263-99. doi: 10.2165/00003088-199630040-00002.
9
Quinine specifically inhibits the proteolipid subunit of the F0F1 H+ -ATPase of Streptococcus pneumoniae.奎宁特异性抑制肺炎链球菌F0F1 H+ -ATP酶的蛋白脂质亚基。
J Bacteriol. 1996 Apr;178(8):2455-8. doi: 10.1128/jb.178.8.2455-2458.1996.
10
Diagnosis and treatment of malaria in Britain.英国疟疾的诊断与治疗
BMJ. 1993 May 1;306(6886):1175-80. doi: 10.1136/bmj.306.6886.1175.